Ignite Creation Date:
2025-12-24 @ 3:00 PM
Ignite Modification Date:
2026-01-29 @ 5:04 PM
Study NCT ID:
NCT00723359
Status:
COMPLETED
Last Update Posted:
2013-07-18
First Post:
2008-07-24
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Dose Determining Study of BT062 in Patients With Relapsed or Refractory Multiple Myeloma
Sponsor:
Biotest Pharmaceuticals Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
969
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |